Newsroom
Sorted by: Latest
-
Natixis Syndicate UK Regulatory Announcement: PRE-STABILISATION ANNOUNCEMENT
LONDON--(BUSINESS WIRE)-- Date: 1st September 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Compagnie de Financement Foncier Pre-stabilisation Period Announcement Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with...
-
Nano One Appoints Aleem Ladak as Director of Corporate Development
VANCOUVER, British Columbia--(BUSINESS WIRE)--Nano One® Materials Corp. (“Nano One” or the “Company”) (TSX: NANO) (OTCQB: NNOMF) (Frankfurt: LBMB), a process technology company specializing in lithium-ion battery cathode active materials, has appointed Aleem Ladak, P.Eng., as Director of Corporate Development, effective August 5, 2026, to advance the Company’s commercial and strategic objectives. Mr. Ladak is a critical minerals and battery materials executive with more than 15 years of experie...
-
ZEDEDA and VAS Limited Sign Distribution Agreement to Bring Edge Intelligence to Saudi Arabia
SAN JOSE, Calif. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--ZEDEDA, the leader in edge intelligence, and VAS Limited, a value-added distributor of global technology solutions, today announced a distribution agreement to bring ZEDEDA’s Edge Intelligence Platform to customers across the Kingdom of Saudi Arabia, with plans to expand into the wider GCC region. Deployments across hundreds or thousands of sites are rarely a single product decision. They involve hardware sourcing, multi-vendor integrati...
-
FluoSphera Licenses Debiopharm’s AbYlink™ Technology for 3D Antibody Characterization while Leveraging Leica Microsystems Viventis Deep Imaging Capabilities
GENEVA & LAUSANNE, Switzerland--(BUSINESS WIRE)--Debiopharm (Debiopharm Research & Manufacturing), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases and FluoSphera, a Swiss biotechnology company developing advanced in vitro platforms to improve the prediction of drug efficacy and safety, today announced a new license agreement for use of AbYlink™, Debiopharm’s proprietary antibody conjugation techn...
-
Searchlight Capital Partners Announces Investment in Aderian Group
LONDON & STOCKHOLM--(BUSINESS WIRE)--Searchlight Capital Partners, L.P. ("Searchlight"), a leading global private investment firm, today announced an investment in Aderian Group ("Aderian" or the "Company"), a Nordic managed IT services provider serving more than 10,000 small and medium-sized enterprise ("SME") customers throughout Sweden and Norway. As part of the transaction, Aderian's management team will reinvest in the Company and remain meaningful shareholders alongside Searchlight, under...
-
Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds
CHICAGO--(BUSINESS WIRE)--Global sales of consumer technology and durable goods are forecast to reach $1.4 trillion in 2026, up 5.1% year over year, even as 56% of consumers say they have delayed a technology purchase because of price or while waiting for a discount, according to new research from NIQ (NYSE: NIQ), the Official Global Insights Partner of IFA. Released ahead of IFA 2026, which kicks off in Berlin on Sept. 4, 2026, NIQ today released its annual “State of Tech & Durables” repor...
-
Aegir Insights launches AI decision layer combining global renewables intelligence with deterministic modeling
COPENHAGEN, Denmark--(BUSINESS WIRE)--Aegir Insights launches Ask Aegir and MCP connector. An AI decision layer linking renewable energy intelligence to deterministic investment modeling....
-
John Pissanos Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group
LONDON--(BUSINESS WIRE)--Evercore announced today that John Pissanos has joined the firm as a senior managing director in its healthcare investment banking group, focused on life science tools & diagnostics and medtech. He will be based in London. “We are delighted to welcome John to Evercore,” said Giuseppe Monarchi, co-head of Evercore's EMEA investment banking business. “John is a highly regarded healthcare banker with deep relationships across the sector and a strong track record advisi...
-
TotalEnergies SE UK Regulatory Announcement: Emmanuelle Guégan appointed President Marketing & Services and member of TotalEnergies’ Executive Committee
PARIS--(BUSINESS WIRE)-- Effective September 1, 2026, Emmanuelle Guégan is appointed President Marketing & Services and member of the Executive Committee, Bernard Pinatel having decided to retire. Emmanuelle Guégan had been Senior Vice President Corporate Affairs of TotalEnergies’ (Paris:TTE) (LSE:TTE) (NYSE:TTE) Exploration & Production since October 2025. “I would like to warmly thank Bernard Pinatel for his longstanding commitment to the Company. Throughout his career, and notably d...
-
Emmanuelle Guégan appointed President Marketing & Services and member of TotalEnergies’ Executive Committee
PARIS--(BUSINESS WIRE)--Effective September 1, 2026, Emmanuelle Guégan is appointed President Marketing & Services and member of the Executive Committee, Bernard Pinatel having decided to retire. Emmanuelle Guégan had been Senior Vice President Corporate Affairs of TotalEnergies’ (Paris:TTE) (LSE:TTE) (NYSE:TTE) Exploration & Production since October 2025. “I would like to warmly thank Bernard Pinatel for his longstanding commitment to the Company. Throughout his career, and notably dur...